Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Network Appliance Inc. (NetApp) unveiled two new midrange storage systems this week, the NetApp FAS3020 and FAS3050, in addition to a new serial ATA (SATA) option for primary storage applications.
A study released in the June issue of the Radiology goes a long way in dispelling the belief that diagnostic imaging is significantly pushing up healthcare costs.
Eizo Nanao Corp. will now bundle Matrox Graphics Inc.'s RAD PCI display controller board with its Eizo RadiForce G22, G21, G20, G11, R22, R12 and upcoming 3 MP color medical displays.
R2 Technology, Inc. has launched an upgrade to its ImageChecker CT Lung Version 2.0 CAD software system with the AutoPoint temporal comparison feature for use during review of multislice CT (MSCT) chest exams.
Evolved Digital Systems Inc. has released its revenue results for first quarter 2005 which totaled at $4.4 million, which is up in comparison to the same period in 2004 which ended at $4.1 million.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
